Curanex Pharmaceuticals Inc Accrued Liabilities, Current
Curanex Pharmaceuticals Inc (CURX) had Accrued Liabilities, Current of $9.74 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $9.74K.
- 2026-03-31: Accrued Liabilities, Current $13.24K.
- 2025-12-31: Accrued Liabilities, Current $11.91K.
- 2025-09-30: Accrued Liabilities, Current $10.32K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $9.74K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $13.24K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $11.91K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $10.32K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $575.00 10-Q · filed 2025-09-09 |
| 2024-12-31 | $9.57K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |